Richard W. Pascoe, President and CEO at Somaxon Pharmaceuticals, Inc. (SOMX), sold 18,750 shares at $0.48 ($9K) on 2012-01-03, disclosed to the SEC on 2012-01-04.
Scheduled sale ($9k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| KMPH | BUY | 2022-05-18 | $23K | — | Filing → |
| KMPH | BUY | 2021-11-30 | $12K | — | Filing → |
| HSTO | BUY | 2021-03-30 | $23K | — | Filing → |